Comparative effects of gastric bypass and sleeve gastrectomy on plasma osteopontin concentrations in humans

Surgical Endoscopy

Volumn 28, Issue 8, 2014, Pages 2412-2420

  Lancha, Andoni ^a,b   Moncada, Rafael ^a   Valentí, Víctor ^a,b   Rodríguez, Amaia ^a,b   Catalán, Victoria ^a,b   Becerril, Sara ^a,b   Ramírez, Beatriz ^a,b   Méndez Giménez, Leire ^a,b   Gil, María J ^a,b   Rotellar, Fernando ^a,b   Fernández, Secundino ^a,b   Salvador, Javier ^a,b   Frühbeck, Gema ^a,b   Gómez Ambrosi, Javier ^a,b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Bone; Osteopontin; Roux en Y gastric bypass; Sleeve gastrectomy

Indexed keywords

ALKALINE PHOSPHATASE; C REACTIVE PROTEIN; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOCALCIN; OSTEOPONTIN; PARATHYROID HORMONE; PHOSPHATE; TRIACYLGLYCEROL; VITAMIN D; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; INSULIN; PEPTIDE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; BONE DENSITY; BONE METABOLISM; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INSULINEMIA; MALE; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; ROUX Y ANASTOMOSIS; SLEEVE GASTRECTOMY; STOMACH BYPASS; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; BLOOD; GASTRECTOMY; MIDDLE AGED; PROCEDURES;

ADULT; ALKALINE PHOSPHATASE; BONE DENSITY; C-REACTIVE PROTEIN; COLLAGEN TYPE I; FEMALE; FIBRINOGEN; GASTRECTOMY; GASTRIC BYPASS; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OSTEOCALCIN; OSTEOPONTIN; PEPTIDES; VITAMIN D; WEIGHT LOSS;

EID: 84906935362     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-014-3490-1     Document Type: Article

References (60)

1. Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML, Gortmaker SL (2011) The global obesity pandemic: shaped by global drivers and local environments. Lancet 378:804-814
2. Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 307:491-497
3. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet MS, Park Y, Pocobelli G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A, Zeleniuch-Jacquotte A, Willett WC, Thun MJ (2010) Body-mass index and mortality among 1.46 million white adults. N Engl J Med 363:2211-2219
4. Ashrafian H, le Roux CW, Darzi A, Athanasiou T (2008) Effects of bariatric surgery on cardiovascular function. Circulation 118:2091-2102
5. Geloneze B, Geloneze SR, Chaim E, Hirsch FF, Felici AC, Lambert G, Tambascia MA, Pareja JC (2012) Metabolic surgery for non-obese type 2 diabetes: incretins, adipocytokines, and insulin secretion/resistance changes in a 1-year interventional clinical controlled study. Ann Surg 256:72-78
6. Sjöström L (2013) Review of the key results from the Swedish Obese Subjects (SOS) trial: a prospective controlled intervention study of bariatric surgery. J Intern Med 273:219-234
7. Pournaras DJ, le Roux CW (2013) Preventing type 2 diabetes, CVD, and mortality: surgical versus non-surgical weight loss strategies. Curr Atheroscler Rep 15:367
8. Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjöström CD, Sullivan M, Wedel H (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683-2693 (Pubitemid 39665322)
9. Gómez-Ambrosi J, Pastor C, Salvador J, Silva C, Rotellar F, Gil MJ, Catalán V, Rodríguez A, Cienfuegos JA, Frühbeck G (2007) Influence of waist circumference on the metabolic risk associated with impaired fasting glucose: effect of weight loss after gastric bypass. Obes Surg 17:585-591
10. Scott WR, Batterham RL (2011) Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. Am J Physiol Regul Integr Comp Physiol 301:R15-R27
11. Gould J, Ellsmere J, Fanelli R, Hutter M, Jones S, Pratt J, Schauer P, Schirmer B, Schwaitzberg S, Jones DB (2011) Panel report: best practices for the surgical treatment of obesity. Surg Endosc 25:1730-1740
12. Romero F, Nicolau J, Flores L, Casamitjana R, Ibarzabal A, Lacy A, Vidal J (2012) Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects. Surg Endosc 26:2231-2239
13. Peeters A, O'Brien PE, Laurie C, Anderson M, Wolfe R, Flum D, MacInnis RJ, English DR, Dixon J (2007) Substantial intentional weight loss and mortality in the severely obese. Ann Surg 246:1028-1033 (Pubitemid 350179196)
14. Sjöstrom L, Narbro K, Sjöstrom CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lonroth H, Naslund I, Olbers T, Stenlof K, Torgerson J, Agren G, Carlsson LM (2007) Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357:741-752 (Pubitemid 47295641)
15. Gómez-Ambrosi J, Catalán V, Ramírez B, Rodríguez A, Colina I, Silva C, Rotellar F, Mugueta C, Gil MJ, Cienfuegos JA, Salvador J, Frühbeck G (2007) Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J Clin Endocrinol Metab 92:3719-3727
16. Gómez-Ambrosi J, Azcona C, Patiño-García A, Frühbeck G (2008) Serum amyloid A concentration is increased in obese children and adolescents. J Pediatr 153:71-75
17. Catalán V, Gómez-Ambrosi J, Rodríguez A, Salvador J, Frühbeck G (2009) Adipokines in the treatment of diabetes mellitus and obesity. Expert Opin Pharmacother 10:239-254
18. Catalán V, Gómez-Ambrosi J, Ramírez B, Rotellar F, Pastor C, Silva C, Rodríguez A, Gil MJ, Cienfuegos JA, Frühbeck G (2007) Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass. Obes Surg 17:1464-1474
19. Forsythe LK, Wallace JM, Livingstone MB (2008) Obesity and inflammation: the effects of weight loss. Nutr Res Rev 21:117-133
20. Tziomalos K, Dimitroula HV, Katsiki N, Savopoulos C, Hatzitolios AI (2010) Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients. Mediat Inflamm 2010:364957
21. Catalán V, Gómez-Ambrosi J, Rodríguez A, Ramírez B, Rotellar F, ValentíV, Silva C, Gil MJ, Fernández-Real JM, Salvador J, Frühbeck G (2011) Increased levels of calprotectin in obesity are related to macrophage content: impact on inflammation and effect of weight loss. Mol Med 17:1157-1167
22. Bertola A, Deveaux V, Bonnafous S, Rousseau D, Anty R, Wakkach A, Dahman M, Tordjman J, Clement K, McQuaid SE, Frayn KN, Huet PM, Gugenheim J, Lotersztajn S, Le Marchand-Brustel Y, Tran A, Gual P (2009) Elevated expression of osteopontin may be related to adipose tissue macrophage accumulation and liver steatosis in morbid obesity. Diabetes 58:125-133
23. Wai PY, Kuo PC (2004) The role of osteopontin in tumor metastasis. J Surg Res 121:228-241 (Pubitemid 39387464)
24. Towler DA, Bidder M, Latifi T, Coleman T, Semenkovich CF (1998) Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptordeficient mice. J Biol Chem 273:30427-30434 (Pubitemid 28545516)
25. Mazzali M, Kipari T, Ophascharoensuk V, Wesson JA, Johnson R, Hughes J (2002) Osteopontin - a molecule for all seasons. QJM 95:3-13
26. O'Regan A (2003) The role of osteopontin in lung disease. Cytokine Growth Factor Rev 14:479-488
27. Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF (2004) Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Am J Physiol Gastrointest Liver Physiol 287:G264-G273 (Pubitemid 38802141)
28. Scatena M, Liaw L, Giachelli CM (2007) Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 27:2302-2309 (Pubitemid 350203943)
29. Hurtado del Pozo CH, Calvo RM, Vesperinas-García G, Gómez-Ambrosi J, Frühbeck G, Rubio MA, Obregón MJ (2011) Expression profile in omental and subcutaneous adipose tissue from lean and obese subjects. Repression of lipolytic and lipogenic genes. Obes Surg 21:633-643
30. Riedl M, Vila G, Maier C, Handisurya A, Shakeri-Manesch S, Prager G, Wagner O, Kautzky-Willer A, Ludvik B, Clodi M, Luger A (2008) Plasma osteopontin increases after bariatric surgery and correlates with markers of bone turnover but not with insulin resistance. J Clin Endocrinol Metab 93:2307-2312 (Pubitemid 351831552)
31. Schaller G, Aso Y, Schernthaner GH, Kopp HP, Inukai T, Kriwanek S, Schernthaner G (2009) Increase of osteopontin plasma concentrations after bariatric surgery independent from inflammation and insulin resistance. Obes Surg 19:351-356
32. Fried M, Yumuk V, Oppert JM, Scopinaro N, Torres AJ, Weiner R, Yashkov Y, Frühbeck G (2013) Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Facts 6: 449-468
33. Gómez-Ambrosi J, Silva C, GalofréJC, Escalada J, Santos S, Gil MJ, ValentíV, Rotellar F, Ramírez B, Salvador J, Frühbeck G (2011) Body adiposity and type 2 diabetes: increased risk with a high body fat percentage even having a normal BMI. Obesity (Silver Spring) 19:1439-1444
34. Gómez-Ambrosi J, Silva C, GalofréJC, Escalada J, Santos S, Millán D, Vila N, Ibañez P, Gil MJ, ValentíV, Rotellar F, Ramírez B, Salvador J, Frühbeck G (2012) Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes (Lond) 36:286-294
35. Gómez-Ambrosi J, Salvador J, Rotellar F, Silva C, Catalán V, Rodríguez A, Gil MJ, Frühbeck G (2006) Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass. Obes Surg 16:262-269
36. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 (Pubitemid 15018832)
37. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402-2410 (Pubitemid 32269192)
38. Bal BS, Finelli FC, Shope TR, Koch TR (2012) Nutritional deficiencies after bariatric surgery. Nat Rev Endocrinol 8:544-556
39. Vilarrasa N, de Gordejuela AG, Gomez-Vaquero C, Pujol J, Elio I, San Jose P, Toro S, Casajoana A, Gomez JM (2013) Effect of bariatric surgery on bone mineral density: comparison of gastric bypass and sleeve gastrectomy. Obes Surg 23:2086-2091
40. Ruiz-Tovar J, Oller I, Priego P, Arroyo A, Calero A, Diez M, Zubiaga L, Calpena R (2013) Short- and mid-term changes in bone mineral density after laparoscopic sleeve gastrectomy. Obes Surg 23:861-866
41. Coates PS, Fernstrom JD, Fernstrom MH, Schauer PR, Greenspan SL (2004) Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab 89:1061-1065 (Pubitemid 38368390)
42. Gómez JM, Vilarrasa N, Masdevall C, Pujol J, Solano E, Soler J, Elio I, Gallart L, Vendrell J (2009) Regulation of bone mineral density in morbidly obese women: a cross-sectional study in two cohorts before and after bypass surgery. Obes Surg 19:345-350
43. Okamoto N, Aruga S, Tomita K, Takeuchi T, Kitamura T (2007) Chronic acid ingestion promotes renal stone formation in rats treated with vitamin D3. Int J Urol 14:60-66 (Pubitemid 44952584)
44. -/-) mice with chronic renal failure. Nephrol Dial Transplant 23:82-90
45. Stemmer K, Bielohuby M, Grayson BE, Begg DP, Chambers AP, Neff C, Woods SC, Erben RG, Tschop MH, Bidlingmaier M, Clemens TL, Seeley RJ (2013) Roux-en-Y gastric bypass surgery but not vertical sleeve gastrectomy decreases bone mass in male rats. Endocrinology 154:2015-2024
46. Canales BK, Reyes L, Reinhard MK, Khan SR, Goncalves CG, Meguid MM (2012) Renal glomerular and tubular injury after gastric bypass in obese rats. Nutrition 28:76-80
47. Folli F, Sabowitz BN, Schwesinger W, Fanti P, Guardado-Mendoza R, Muscogiuri G (2012) Bariatric surgery and bone disease: from clinical perspective to molecular insights. Int J Obes (Lond) 36:1373-1379
48. +/- mice. Cancer Prev Res (Phila) 3:1246-1258
49. Wang F, Jiang T, Tang C, Su Z, Zhang N, Li G (2011) Ghrelin reduces rat myocardial calcification induced by nicotine and vitamin D3 in vivo. Int J Mol Med 28:513-519
50. Komorowski J, Jankiewicz-Wika J, Kolomecki K, Cywinski J, Piestrzeniewicz K, Swietoslawski J, Stepien H (2011) Systemic blood osteopontin, endostatin, and E-selectin concentrations after vertical banding surgery in severely obese adults. Cytokine 55:56-61
51. Frühbeck G, Diez Caballero A, Gil MJ (2004) Fundus functionality and ghrelin concentrations after bariatric surgery. N Engl J Med 350:308-309 (Pubitemid 38067650)
52. Schindler K, Prager G, Ballaban T, Kretschmer S, Riener R, Buranyi B, Maier C, Luger A, Ludvik B (2004) Impact of laparoscopic adjustable gastric banding on plasma ghrelin, eating behaviour and body weight. Eur J Clin Invest 34:549-554 (Pubitemid 39120224)
53. Foschi D, Corsi F, Colombo F, Vago T, Bevilaqua M, Rizzi A, Trabucchi E (2008) Different effects of vertical banded gastroplasty and Roux-en-Y gastric bypass on meal inhibition of ghrelin secretion in morbidly obese patients. J Invest Surg 21:77-81 (Pubitemid 351404804)
54. Li GZ, Jiang W, Zhao J, Pan CS, Cao J, Tang CS, Chang L (2005) Ghrelin blunted vascular calcification in vivo and in vitro in rats. Regul Pept 129:167-176 (Pubitemid 40775800)
55. Nomiyama T, Perez-Tilve D, Ogawa D, Gizard F, Zhao Y, Heywood EB, Jones KL, Kawamori R, Cassis LA, Tschop MH, Bruemmer D (2007) Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest 117:2877-2888 (Pubitemid 47529618)
56. Kiefer FW, Zeyda M, Todoric J, Huber J, Geyeregger R, Weichhart T, Aszmann O, Ludvik B, Silberhumer GR, Prager G, Stulnig TM (2008) Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations. Endocrinology 149:1350-1357 (Pubitemid 351397930)
57. Chapman J, Miles PD, Ofrecio JM, Neels JG, Yu JG, Resnik JL, Wilkes J, Talukdar S, Thapar D, Johnson K, Sears DD (2010) Osteopontin is required for the early onset of high fat diet-induced insulin resistance in mice. PLoS ONE 5:e13959
58. Kiefer FW, Zeyda M, Gollinger K, Pfau B, Neuhofer A, Weichhart T, Saemann MD, Geyeregger R, Schlederer M, Kenner L, Stulnig TM (2010) Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance. Diabetes 59:935-946
59. Kiefer FW, Neschen S, Pfau B, Legerer B, Neuhofer A, Kahle M, Hrabe de Angelis M, Schlederer M, Mair M, Kenner L, Plutzky J, Zeyda M, Stulnig TM (2011) Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice. Diabetologia 54:2132-2142
60. Lancha A, Frühbeck G, Gómez-Ambrosi J (2012) Peripheral signalling involved in energy homeostasis control. Nutr Res Rev 25:223-248